NERISONE

This brand name is authorized in France, Germany, Hong Kong SAR China, New Zealand, South Africa, UK.

Active ingredients

The drug NERISONE contains one active pharmaceutical ingredient (API):

1	Diflucortolone UNII 1A63Z067C8 - DIFLUCORTOLONE VALERATE
	Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain.
	Read more about Diflucortolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NERISONE Cream, Ointment	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07AC06	Diflucortolone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00247315, 00247338, 00247545, 00247893, 07548273, 07548296
FR	Base de données publique des médicaments	62017113, 63420875, 67945482
GB	Medicines & Healthcare Products Regulatory Agency	25698, 38360, 38367, 39616, 39623
HK	Department of Health Drug Office	43570
NZ	Medicines and Medical Devices Safety Authority	2372
ZA	Health Products Regulatory Authority	H/13.4.1/218, H/13.4.1/219, H/13.4.1/220, R/13.4.1/26, R/13.4.1/27